Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Contractor for clinician-focused addiction recovery program sued over ‘punishingly expensive’ practices
The plaintiffs, 10 nurses and one doctor, are all enrolled in the state-mandated initiative for clinicians with past substance abuse issues. The rules require monitoring and regular drug testing to prove sobriety; however, the lot argues that the contractor in charge, Maximus, is being dishonestly punitive.
COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination
Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.
How to minimize bleeding risks after TAVR
Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.
Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly
Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.

SGLT2 inhibitors after TAVR may boost survival, limit bioprosthetic valve dysfunction

Prescribing these drugs to TAVR patients could improve certain clinical outcomes, according to a new study of nearly 27,000 adults.

Field Medical FieldForce Ablation pulsed field ablation

Field Medical’s PFA system for ventricular tachycardia shows early potential

More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.

James Muller, MD, explains advances in vulnerable plaque imaging aim to predict and prevent heart attacks.

Advances in imaging could help predict, prevent heart attacks

Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.

FDA clears AI-powered vascular imaging software

The new software provides automated measurements that save time and improve the care of aortic aneurysm patients.

healthcare value value-based care money dollar

Cardiologist compensation hits an all-time high

Cardiologists, cardiac surgeons and cardiology APPs all earned more in 2024 than 2023, according to a new survey. Compensation in private practices continues to be much lower than it is integrated practices.

Medtech companies working together on robotic PFA system

Stereotaxis and CardioFocus are collaborating on a new robotic pulsed field ablation system. After completing some initial research, the companies are now working toward the launch of a clinical trial.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

Performing PCI and TAVR together may improve in-hospital outcomes, long-term survival

When patients require PCI and TAVR, performing them at the same time is associated with both short- and long-term benefits.

Industry partnership seeks to bolster supply of radioisotopes

Two key companies shared the news Oct. 14, highlighting the potential their partnership has for improving oncologic care.

Clinical

Contractor for clinician-focused addiction recovery program sued over ‘punishingly expensive’ practices

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination

How to minimize bleeding risks after TAVR

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Private equity-backed Medline files for IPO